Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Deborah H. Charych
Efficacy and Immune Modulation of the Tumor Microenvironment With the Combination of the PARP Inhibitor Rucaparib and CD122-biased Agonist NKTR-214.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Bempegaldesleukin (NKTR-214): A CD-122-biased IL-2 Receptor Agonist for Cancer Immunotherapy
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
Nanoparticle Modulation of the Tumor Microenvironment Enhances Therapeutic Efficacy of Cisplatin
Journal of Controlled Release
Pharmaceutical Science
Chemokine Modulation of the Tumor Microenvironment
Pigment Cell and Melanoma Research
Biochemistry
Dermatology
Oncology
Genetics
Molecular Biology
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-Pd-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment
Journal of Cancer
Oncology
Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination
Clinical Cancer Research
Cancer Research
Oncology
Development of PARP and Immune-Checkpoint Inhibitor Combinations
Cancer Research
Cancer Research
Oncology
Multiplexed Imaging Characterizes the Tumor–Immune Microenvironment
Cancer Discovery
Oncology
Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune Checkpoint Blockade
Clinical Cancer Research
Cancer Research
Oncology
Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
Frontiers in Immunology
Allergy
Immunology